235 related articles for article (PubMed ID: 29231142)
1. CRISPR-Cas in Medicinal Chemistry: Applications and Regulatory Concerns.
Duardo-Sanchez A
Curr Top Med Chem; 2017; 17(30):3308-3315. PubMed ID: 29231142
[TBL] [Abstract][Full Text] [Related]
2. [Crispr-Cas9 Gene Editing Revolution and the Its Ethical and Legal Challenges].
Bellver Capella V
Cuad Bioet; 2016; 27(90):223-39. PubMed ID: 27637196
[TBL] [Abstract][Full Text] [Related]
3. [CRISPR/Cas: technique to repair DNA errors: is a clinical breakthrough near?].
van de Vrugt HJ; Cornel MC; Wolthuis RMF
Ned Tijdschr Geneeskd; 2018 Jun; 162():. PubMed ID: 30040285
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-Cpf1: A New Tool for Plant Genome Editing.
Zaidi SS; Mahfouz MM; Mansoor S
Trends Plant Sci; 2017 Jul; 22(7):550-553. PubMed ID: 28532598
[TBL] [Abstract][Full Text] [Related]
5. Starting the conversation: CRISPR's role in India.
Udwadia F; Singh S
Indian J Med Ethics; 2019; 4 (NS)(4):300-303. PubMed ID: 31213419
[TBL] [Abstract][Full Text] [Related]
6. CRISPR and the Law: A South African Perspective.
Soni S
CRISPR J; 2020 Apr; 3(2):81-82. PubMed ID: 32315223
[No Abstract] [Full Text] [Related]
7. The morality and ethics governing CRISPR-Cas9 patents in China.
Peng Y
Nat Biotechnol; 2016 Jun; 34(6):616-8. PubMed ID: 27281418
[No Abstract] [Full Text] [Related]
8. Legal issues regarding gene editing at the beginning of life: an EU perspective.
De Miguel Beriain I
Regen Med; 2017 Sep; 12(6):669-679. PubMed ID: 28976851
[TBL] [Abstract][Full Text] [Related]
9. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
Xu R; Wei P; Yang J
Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
[TBL] [Abstract][Full Text] [Related]
10. FDA Regulation of Clinical Applications of CRISPR-CAS Gene-Editing Technology.
Grant EV
Food Drug Law J; 2016; 71(4):608-33. PubMed ID: 29140647
[TBL] [Abstract][Full Text] [Related]
11. Thinking About CRISPR: The Ethics of Human Genome Editing.
Barrangou R
CRISPR J; 2019 Oct; 2(5):247-248. PubMed ID: 31599676
[No Abstract] [Full Text] [Related]
12. A CRISPR Moratorium Isn't Enough: We Need a Boycott.
Hough SH; Ajetunmobi A
CRISPR J; 2019 Dec; 2(6):343-345. PubMed ID: 31860353
[No Abstract] [Full Text] [Related]
13. The better edge of the CRISPR blade.
The Lancet
Lancet; 2020 Jan; 395(10218):90. PubMed ID: 31929016
[No Abstract] [Full Text] [Related]
14. Human Genome Editing and Ethical Considerations.
Krishan K; Kanchan T; Singh B
Sci Eng Ethics; 2016 Apr; 22(2):597-9. PubMed ID: 26154417
[TBL] [Abstract][Full Text] [Related]
15. [CRISPR-Cas system as molecular scissors for gene therapy].
Heinz GA; Mashreghi MF
Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
[TBL] [Abstract][Full Text] [Related]
16. A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila.
Xu J; Ren X; Sun J; Wang X; Qiao HH; Xu BW; Liu LP; Ni JQ
J Genet Genomics; 2015 Apr; 42(4):141-9. PubMed ID: 25953352
[TBL] [Abstract][Full Text] [Related]
17. Comments on the CRISPR Gene-edited babies' case.
Cong Y
Indian J Med Ethics; 2019; 4 (NS)(4):297-300. PubMed ID: 31791938
[TBL] [Abstract][Full Text] [Related]
18. Progress and Application of CRISPR/Cas Technology in Biological and Biomedical Investigation.
Lin J; Zhou Y; Liu J; Chen J; Chen W; Zhao S; Wu Z; Wu N
J Cell Biochem; 2017 Oct; 118(10):3061-3071. PubMed ID: 28590031
[TBL] [Abstract][Full Text] [Related]
19. CRISPR technologies for bacterial systems: Current achievements and future directions.
Choi KR; Lee SY
Biotechnol Adv; 2016 Nov; 34(7):1180-1209. PubMed ID: 27566508
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas in Arabidopsis: overcoming challenges to accelerate improvements in crop photosynthetic efficiencies.
Khumsupan P; Donovan S; McCormick AJ
Physiol Plant; 2019 May; 166(1):428-437. PubMed ID: 30706492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
